| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |